I agree with your target, my last target was 65 but it was exceeded. That call was made when the stock was at support in the rising channel around 42. Now I have added a starter position, still think there may be one swoon down to the level of the 200 dma (50.48) or possibly as low as the 250 dma which is 49.17 now. I have my shares now averaged at 53.87 in case it doesn't happen, but if it does, my GTC order will be waiting for a fill at $50. What is your idea, have we hit the bottom of this move?
Thanks for sharing your story, I am also invested both here and in MSTX, where I have the highest number of shares in any one stock. I like their platform and chances for success, think it could become a $4 stock, in time. I like some of the others, just "can't dance with all the girls".
Patience is a better strategy than hoping, keeping faith too, knowing what you own. I am increasing my DD as I go into summer, when many of our biotech stocks may fade. I want to be rock solid with knowing what I own, instead of reading MB's so much. I admire theswiper who is going to take time away and be back in the fall.
Sounds reasonable, I've been calling it a $40 stock for the past month, so we agree, other than what isn't priced in that TW has in his sights. Within the space, they are over the top in their management and execution, so comparing to DEPO or LCI which I have invested in before and made money, this is the best of breed. I have just opened a position in LCI at 53.50, down from recent highs of 72.
I don't know anyone else who can say they've done that well, you must be very good at timing your buys and sells. Do you use technical analysis? What tools do you find most beneficial? What is your top pick now?
If you examine these two companies and their stock price and movements, they are trading just like each other and almost the same price, same today both down 5 cents. Both have great upside possibilities, both been beaten down. I own shares in both companies, 5,000 shares each, bought in recently so marginally down, not much. Basis here is 2.41 and there is 2.27. I think the same hedge fund is probably shorting both of them, knowing that management isn't going to have anything with which to support the stock until trial results are in.
It's been wild here, pops and drops, get it over with, my shares are locked down, done adding. Run it up, longs here are time tested, been there and done that. Management, the stage is set for you guys to put the bridle on this wild thing!
Do you enjoy hiking on trails? Biotech companies conduct trials for the pipeline candidates. So, are we hiking or in the lab?
Yes, and thanks for the kind words, you are one of my favorite posters, we will persist anf prosper together, and by being early, we will get ALL of the upside to the last day in the life of our investment!
I agree with you, it's no longer just blind faith here, the time compression is hurting the stock, and Riley has no control over the 'MRI release' timing. I have appropriately downsized my stake here, it's coming down to a binary event just ahead, and there has been no let up in the selling pressure. Today could be characterized as a capitulation trade, insofar as it was a big down move on volume (1.25MM shares traded), coming off its lows mid session. I'd like to think we are there, but doubt remains.
I've got one position where I'm being cooked right now, you are right, by degrees and gradual, we can take it, but the shock of it all at once would be intolerable and although we'd sustain fatal burns, we'd get out fast. I will see this one through, the stock is IDRA.
I was watching that, there was a steady stream of large blocks selling into the drop, maybe it will be a capitulation kind of day, hope so. HughHaggerty was mentioning he thought we'd see support at 2.70 and lowest 2.65. I wouldn't have guessed we'd be back here after the recent green candles took us back over $3.00 but shows you how aimless this stock is now.
I gain courage to hold (and add to) this kind of position by knowing I have like company in people like you Jackie, and you Matt, and MGM2020, Hugh, Amano7, I know I wouldn't still be here without my IDRA friends. I do my DD of course, lots of sources, but am more of a team player than a data miner, or intellectual. I am analytical, love the charts, and have picked some good winners, but my favorite pastime is reading and contributing to the message boards where I invest.
newbiemike123! OMG,5 that stock sucks, glad I packed up and left! I was one of the lucky ones, didn't have a bag for too long and didn't get trapped like many there now. I left that one for HZNP for a major ride up, now have a much larger diversified portfolio, keeping 17,000 shares of HZNP, plus a host of other good companies. OSIR since December is now working out well, TROV has been excellent, BIOC may yet prove out in blood liquid biopsy, and some new plays NBS, SNTA, at the recent lows, and MSTX big position at .52. Are you enjoying the biotech market?
The 200 dma is 1.89, which we clearly touched and closed above today. Today could have marked the end of this long consolidation. I now hold a fraction of my original position, having sold 60,000 shares from 2.41 down to 2.07 the day before the conference call. Today I was watching to re-enter and buy some shares back. What I have realized is this is a difficult buy and hold proposition, and should have been a trade for me, out at $3, and back in under $2.00. I am not a trader mentality, so my funds from my SYN profits went to stocks that have earnings and more predictability. I still like the chances here and think under $2.00 is a good bet.
That was a very emphatic bearish engulfing bar put into the chart today, seems the symmetrical triangle formation now has a big red question mark at the apex. I don't know what is next, could go up or down. I know I'm right on this statement!
The thrill is gone? Isn't that a famous song? Seems we have passed into the realm of having to earn our increases in share price, it's no longer a pump with a pop, on high volume swings. I have a decent position, looking for the next opportunity to take decent profits. Until then, I have faith that the paradigm shift to liquid biopsy is making good inroads into the standard of care mindset. Remember the breast cancer and non-small cell lung cancer markets are huge, they don't need a huge market share to be wildly profitable.
Where do you see that? This is from today's 10Q filing. "As of March 31, 2015, our cash and cash equivalents totaled $19.3 million, and our outstanding indebtedness totaled $5.3 million (including $0.1 million of interest accrued thereon, and excluding $0.3 million of associated debt discounts). On February 13, 2015, we received net cash proceeds of $9.1 million as a result of the closing of our follow-on public offering, before deducting $0.3 million of additional non-underwriting costs incurred. As of May 6, 2015, additional cash proceeds of $8.5 million have been received from the exercise of warrants sold in such offering. Management believes that its cash resources should be sufficient to support currently forecasted operations through at least the next twelve months. While we currently are in the commercialization stage of operations, we have not yet achieved profitability and anticipate that we will continue to incur net losses for the foreseeable future."
They will do another raise eventually, but as of today's filing, they aren't planning a raise now.
Yes, we cleared that 17.57 resistance point today, it is good to see the share demand increase, and nothing too frenetic either, just a steady advance on 201,200 share volume. Monday's volume of 693,941 was the highest volume day since one year ago in early June. Next resistance is at 18.41, then 19.75, then 27.40 all time high.